by Ingrid Kroeze | Apr 29, 2024 | News
Excellion (Nigeria) and OncoInv (The Netherlands) have joined forces to make multi cancer early detection available in Nigeria. OncoSeek® is a patient-friendly product to detect cancer as it is on a blood sample and requires no biopsy or imaging equipment. OncoSeek®...
by Ingrid Kroeze | Apr 12, 2024 | News
Two Sample Types, Three Different Platforms, Six Independent Cohorts of ~12,000 Cancer Patients and Non-cancer Individuals with Diverse Ethnic Backgrounds in Retrospective and Prospective Settings Validate OncoSeek’s Ability to Detect Multiple Cancer Types and...
by Ingrid Kroeze | Apr 10, 2024 | News
In Poland, cancers are detected in late stages, which makes effective treatment impossible. OnkoDiag places great emphasis on cancer prevention and that’s why they have chosen OncoSeek® for its offer. OncoSeek® is a patient-friendly product to detect cancer as...
by Ingrid Kroeze | Jan 9, 2024 | News
NM Genomix (Bulgaria) and OncoInv (the Netherlands) have joined forces to make multi cancer early detection available in Bulgaria. OncoSeek® is a patient-friendly product to detect cancer as it is on a blood sample and requires no biopsy or imaging equipment. Starting...
by Ingrid Kroeze | Dec 15, 2023 | News
Worldwide each year, 19.3 million people are diagnosed with cancer and the numbers are growing. Nearly 1 in 6 deaths is caused by cancer. The need to expedite diagnostics is vital. As more and curative treatments options are available the earlier cancer is diagnosed...
by Ingrid Kroeze | Dec 1, 2023 | News
SeekIn and OncoInv have joined forces to make multi-cancer early detection (MCED) accessible in low- and middle-income countries (LMICs). SeekIn has developed several blood-based solutions to simplify and enhance cancer diagnosis and analysis. This technology can be...
